Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
4.910
-0.130 (-2.58%)
At close: Oct 24, 2024, 4:00 PM
4.960
+0.050 (1.02%)
After-hours: Oct 24, 2024, 5:33 PM EDT
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $474.40 million as of October 24, 2024. Its market cap has decreased by -9.31% in one year.
Market Cap
474.40M
Enterprise Value
782.42M
1-Year Change
-9.31%
Ranking
Category
Stock Price
$4.91
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $474.40M, a decrease of -91.63%. That is a compound annual growth rate of -32.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 427.70M | 0.94% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Health Catalyst | 488.60M |
| PureTech Health | 485.22M |
| REGENXBIO | 481.38M |
| Altimmune | 477.60M |
| Pacific Biosciences of California | 476.93M |
| Corvus Pharmaceuticals | 472.89M |
| Emergent BioSolutions | 472.67M |
| SIGA Technologies | 471.75M |